Cannabidiol-enriched oil in children and adults with treatment-resistant epilepsy-does tolerance exist?

Shimrit Uliel-Sibony, Moran Hausman-Kedem, Aviva Fattal-Valevski, Uri Kramer

Research output: Contribution to journalArticlepeer-review

Abstract

Aim: To evaluate the long-term effectiveness of cannabidiol (CBD)-enriched oil for the treatment of refractory epilepsy and to assess the development of tolerance to its anti-seizure effect. Methods: A prospective study of 92 consecutive patients (age 1–37 years, mean-11.8 years) with treatment resistant epilepsy who were treated with cannabis oil extract (CBD/tetrahydrocannabinol [THC] ratio of 20:1). Mean monthly seizure frequency was reported by the patients/their parents during monthly clinic visits. Tolerance was defined as either the need to increase the dose by ≥30% due to reduced treatment efficacy or as an increase of ≥30% in mean monthly seizure frequency in patients treated for at least 3 months with no change in other anti-seizure medications. Results: Mean follow-up time was 19.8 ± 12.5 months (range 3–45). Mean CBD dose was 11.3 (4–38) mg/kg/day. Twenty-nine (31%) patients discontinued treatment due to lack of effect or adverse reactions, which were reported in 51% (47/87) of the patients. Overall responder rate (>50% seizures reduction) was 54%, whereas 8 patients (9%) became seizure-free. Eighty-four patients were included in the tolerance analysis. Tolerance was observed in 21 (25%) patients after a mean duration of 7.3 ± 5.4 months of CBD-enriched oil treatment. There was a negative correlation between epilepsy duration and tolerance development (p = 0.038). Conclusions: We report for the first time the plausible appearance of tolerance to cannabidiol-enriched oil. This may limit treatment efficacy in the long-term clinical management of refractory epilepsy in both pediatric and adult population. Further studies are needed to investigate potential mechanisms.

Original languageEnglish
Pages (from-to)89-96
Number of pages8
JournalBrain and Development
Volume43
Issue number1
DOIs
StatePublished - Jan 2021

Keywords

  • CBD
  • CBD-enriched oil
  • Cannabidiol
  • Cannabis
  • Refractory epilepsy
  • Tolerance

Fingerprint

Dive into the research topics of 'Cannabidiol-enriched oil in children and adults with treatment-resistant epilepsy-does tolerance exist?'. Together they form a unique fingerprint.

Cite this